136 related articles for article (PubMed ID: 7638082)
1. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma.
Friedrich B; Grönberg H; Landström M; Gullberg M; Bergh A
Prostate; 1995 Aug; 27(2):102-9. PubMed ID: 7638082
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas.
Chen G; Wang H; Gharib TG; Huang CC; Thomas DG; Shedden KA; Kuick R; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
Mol Cell Proteomics; 2003 Feb; 2(2):107-16. PubMed ID: 12644570
[TBL] [Abstract][Full Text] [Related]
3. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells.
Brattsand G; Roos G; Marklund U; Ueda H; Landberg G; Nånberg E; Sideras P; Gullberg M
Leukemia; 1993 Apr; 7(4):569-79. PubMed ID: 8464235
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas.
Nylander K; Marklund U; Brattsand G; Gullberg M; Roos G
Histochem J; 1995 Feb; 27(2):155-60. PubMed ID: 7775200
[TBL] [Abstract][Full Text] [Related]
6. The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer.
Price DK; Ball JR; Bahrani-Mostafavi Z; Vachris JC; Kaufman JS; Naumann RW; Higgins RV; Hall JB
Cancer Invest; 2000; 18(8):722-30. PubMed ID: 11107442
[TBL] [Abstract][Full Text] [Related]
7. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors.
Brattsand G
Br J Cancer; 2000 Aug; 83(3):311-8. PubMed ID: 10917544
[TBL] [Abstract][Full Text] [Related]
8. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
9. Expression of oncoprotein 18 in human leukemias and lymphomas.
Roos G; Brattsand G; Landberg G; Marklund U; Gullberg M
Leukemia; 1993 Oct; 7(10):1538-46. PubMed ID: 8412315
[TBL] [Abstract][Full Text] [Related]
10. Expression of the apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy.
Lipponen P; Vesalainen S
Prostate; 1997 Jun; 32(1):9-15. PubMed ID: 9207952
[TBL] [Abstract][Full Text] [Related]
11. Intermediate filament expression and the progression of prostatic cancer as studied in the Dunning R-3327 rat prostatic carcinoma system.
Ramaekers FC; Verhagen AP; Isaacs JT; Feitz WF; Moesker O; Schaart G; Schalken JA; Vooijs GP
Prostate; 1989; 14(4):323-39. PubMed ID: 2664736
[TBL] [Abstract][Full Text] [Related]
12. Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells.
Nishio K; Nakamura T; Koh Y; Kanzawa F; Tamura T; Saijo N
Cancer; 2001 Apr; 91(8):1494-9. PubMed ID: 11301397
[TBL] [Abstract][Full Text] [Related]
13. Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA.
Hanke M; Dubois J; Kausch I; Petkovic S; Sczakiel G
PLoS One; 2020; 15(7):e0229193. PubMed ID: 32614890
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue.
Blanco M; Robinson MJ
Ann Diagn Pathol; 2004 Dec; 8(6):333-6. PubMed ID: 15614736
[TBL] [Abstract][Full Text] [Related]
15. Decreasing oncoprotein 18/stathmin levels reduces microtubule catastrophes and increases microtubule polymer in vivo.
Howell B; Deacon H; Cassimeris L
J Cell Sci; 1999 Nov; 112 ( Pt 21)():3713-22. PubMed ID: 10523507
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
17. Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.
Turhan OI; Aydin NE; Sariyüce O; Ozkan S
Int Urol Nephrol; 1998; 30(6):731-44. PubMed ID: 10195869
[TBL] [Abstract][Full Text] [Related]
18. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
20. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
